Risk Factors for Vancomycin Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome.
Publication
, Journal Article
Blumenthal, KG; Alvarez-Arango, S; Fu, X; Kroshinsky, D; Choi, H; Phillips, E; Zhou, L
Published in: JAMA Dermatol
December 1, 2022
Duke Scholars
Published In
JAMA Dermatol
DOI
EISSN
2168-6084
Publication Date
December 1, 2022
Volume
158
Issue
12
Start / End Page
1449 / 1453
Location
United States
Related Subject Headings
- Vancomycin
- Risk Factors
- Humans
- Eosinophilia
- Drug Hypersensitivity Syndrome
- Anti-Bacterial Agents
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Blumenthal, K. G., Alvarez-Arango, S., Fu, X., Kroshinsky, D., Choi, H., Phillips, E., & Zhou, L. (2022). Risk Factors for Vancomycin Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome. JAMA Dermatol, 158(12), 1449–1453. https://doi.org/10.1001/jamadermatol.2022.3541
Blumenthal, Kimberly G., Santiago Alvarez-Arango, Xiaoqing Fu, Daniela Kroshinsky, Hyon Choi, Elizabeth Phillips, and Li Zhou. “Risk Factors for Vancomycin Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome.” JAMA Dermatol 158, no. 12 (December 1, 2022): 1449–53. https://doi.org/10.1001/jamadermatol.2022.3541.
Blumenthal KG, Alvarez-Arango S, Fu X, Kroshinsky D, Choi H, Phillips E, et al. Risk Factors for Vancomycin Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome. JAMA Dermatol. 2022 Dec 1;158(12):1449–53.
Blumenthal, Kimberly G., et al. “Risk Factors for Vancomycin Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome.” JAMA Dermatol, vol. 158, no. 12, Dec. 2022, pp. 1449–53. Pubmed, doi:10.1001/jamadermatol.2022.3541.
Blumenthal KG, Alvarez-Arango S, Fu X, Kroshinsky D, Choi H, Phillips E, Zhou L. Risk Factors for Vancomycin Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome. JAMA Dermatol. 2022 Dec 1;158(12):1449–1453.
Published In
JAMA Dermatol
DOI
EISSN
2168-6084
Publication Date
December 1, 2022
Volume
158
Issue
12
Start / End Page
1449 / 1453
Location
United States
Related Subject Headings
- Vancomycin
- Risk Factors
- Humans
- Eosinophilia
- Drug Hypersensitivity Syndrome
- Anti-Bacterial Agents
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences